Health Trials

Warm Autoimmune Hemolytic Anemia (WAIHA)

1

Review clinical trials related to Warm Autoimmune Hemolytic Anemia (WAIHA). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

This is a single-arm, open-label, multicenter, ascending dose Phase 1/2 trial evaluating the safety and preliminary efficacy of CTX112 or Zugocabtagene geleucel (zugo-cel) in adult participants with relapsed/refractory primary Immune Thrombocytopenia (ITP) and relapsed/refractory primary Warm Autoimmune Hemolytic Anemia (wAIHA).

Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: CRISPR Therapeutics AGUpdated: Jun 15, 2026Locations: 3
Eligibility criteria

Age ≥18 years. [+5]

Prior treatment with anti-CD19 therapy or any gene therapy or genetically modifi... [+10]

Read more